Stockysis Logo
  • Login
  • Register
  • EN
    Translate page
    EN English ES Español FR Français DE Deutsch ZH 中文 AR العربية PT Português RU Русский JA 日本語 KO 한국어 HI हिन्दी IT Italiano
Back to News

Vistagen Says Fasedienol Well-Tolerated Up To 12 Months In Preliminary Open-Label Extension Of Phase 3 Social Anxiety Trial; Plans FDA Meeting This Quarter On New Phase 3

Benzinga Newsdesk www.benzinga.com Positive 93.5%
Neg 0% Neu 0% Pos 93.5%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Stockysis © 2026 BISSINT LLC.
Blog Terms of Service Contact Us